fda approval
How FDA Approvals Cut Longevity Science Costs 3×
How FDA Approvals Cut Longevity Science Costs 3× In 2023, Medicare Advantage plans reported a 25% drop in annual pharmacy expenses for seniors using newly approved longevity drugs. This means that FDA greenlights for rapamycin and senolytic pills are already translating into three-fold lower out-of-pocket costs for many retirees. Medical